Related Experiment Video
Updated: Jun 12, 2025

09:58
Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
3.4K
RNA and condensates: Disease implications and therapeutic opportunities
Tina W Han1, Bede Portz1, Richard A Young2
1Dewpoint Therapeutics, Boston, MA, USA.
Cell Chemical Biology
|September 20, 2024
Summary
RNA molecules are crucial for biomolecular condensate function. Aberrant RNA in condensates drives diseases like cancer, but targeting RNA within these structures offers new therapeutic avenues.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Biomolecular condensates are membraneless organelles regulating cellular processes by compartmentalizing proteins and RNA.
- RNA molecules play diverse roles in condensate formation, function, and cellular regulation.
Purpose of the Study:
- To review the critical role of RNA in biomolecular condensate biology.
- To elucidate mechanisms of RNA-induced condensate dysregulation and its link to disease.
- To explore novel therapeutic strategies targeting RNA within condensates.
Main Methods:
- Literature review of RNA's involvement in condensate biology.
- Analysis of RNA modification, overexpression, and mislocalization in disease.
- Discussion of emerging therapeutic approaches targeting RNA in condensates.
Main Results:
- RNA abnormalities contribute to pathological condensate behaviors.
- Dysregulated condensates are implicated in cancer, neurological disorders, and infections.
- Targeting RNA within condensates presents a promising therapeutic strategy.
Conclusions:
- RNA is a key regulator of biomolecular condensate dynamics and function.
- RNA dysregulation in condensates drives significant human diseases.
- Novel RNA-centric therapies hold potential for treating complex diseases.
Related Concept Videos
NF-κB-dependent Signaling Pathway
7.3K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.3K
Connective Tissue Cell Types
3.2K
Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
3.2K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
119
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
119
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K

